Literature DB >> 951437

Apomorphine self-injection is not affected by alpha-methylparatyrosine treatment: support for dopaminergic reward.

B L Baxter, M I Gluckman, R A Scerni.   

Abstract

Pretreatment with AMPT at doses which markedly altered the self-injection or amphetamine did not affect the self-injection of apomorphine. These data support the idea that the self-injection of apomorphine is produced via the direct activation of dopamine receptors rather than by the release of either norepinephrine or dopamine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 951437     DOI: 10.1016/0091-3057(76)90205-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Amphetamine- type reinforcement by dopaminergic agonists in the rat.

Authors:  R A Yokel; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

Review 2.  The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction.

Authors:  Magdalena Zaniewska; Małgorzata Filip; Edmund Przegalinski
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.